Incyte INCY
NASDAQ INCY
$127.79 -0.21 (-0.16%)
As of: Sep 4, 2026 · 2:38 PM EDT

Incyte (INCY) Income from Non-Controlling Interests (2019 - 2021)

Incyte's (INCY) quarterly Income from Non-Controlling Interests came in at $300000.0 in Q4 2021, little changed YoY from $300000.0 in Q4 2020, and down 25.0% on a QoQ basis from $400000.0 in Q3 2021.

Analysis

Incyte (INCY) Income from Non-Controlling Interests (2019 - 2021) Analysis & Trends

Incyte (INCY) has 3 years of Income from Non-Controlling Interests data on file, last reported at $300000.0 in Q4 2021.

  • Quarterly Income from Non-Controlling Interests changed 0.0% year-over-year to $300000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.3 million (up 8.33% YoY) and the FY2021 annual result came in at $1.3 million, up 8.33% from the prior year.
  • Income from Non-Controlling Interests declined to $300000.0 in Q4 2021, from $400000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $400000.0 in Q3 2021 to a low of $300000.0 in Q3 2019.
  • A 3-year average of $310000.0 and a median of $300000.0 in 2019 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2020 — Income from Non-Controlling Interests changed 0.0% — and 2021, when it jumped 33.33%.
  • Tracing INCY's Income from Non-Controlling Interests over 3 years: stood at $300000.0 in 2019, then changed by 0.0% to $300000.0 in 2020, then changed by 0.0% to $300000.0 in 2021.
  • The last three Income from Non-Controlling Interests figures came in at $300000.0 (Q4 2021), $400000.0 (Q3 2021), and $300000.0 (Q2 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn -
5 Revolution Medicines 44.06 Bn 44.06 Bn - -
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn -
8 Royalty Pharma 28.41 Bn 27.57 Bn - 63.60 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -
10 Incyte 25.61 Bn 21.07 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 2.62 Mn
Sep 30, 2021 400,000.00
Jun 30, 2021 300,000.00
Mar 31, 2021 300,000.00
Dec 31, 2020 1.58 Mn
Sep 30, 2020 300,000.00
Jun 30, 2020 300,000.00
Mar 31, 2020 300,000.00
Dec 31, 2019 4.80 Mn
Sep 30, 2019 300,000.00